
NeuroBo Pharmaceuticals Inc (NRBO)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -102.222 | -152.681 | -122.12 | -124.77 | -233.354 | -110.088 | -55.498 | -44.287 |
Return on Equity (%) | -362.385 | -271.965 | -403.534 | -212.419 | -304.468 | -140.22 | -76.854 | -64.889 |
Return on Invested Capital (%) | -397.888 | -199.302 | -223.776 | -201.177 | -304.858 | -140.349 | -108.003 | -82.709 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 2.226 | 0.371 | 0.545 | 0.788 | 0.366 | 0.547 | 0.855 | 0.43 |
Earnings Per Share | -1.613 | -3.143 | -1.657 | -1.367 | -1.509 | -0.573 | -0.549 | -0.321 |
Cash Per Share | 2.593 | 1.737 | 1.329 | 0.892 | 0.513 | 0.615 | 1.312 | 0.578 |
Working Capital Per Share | 2.225 | 1.187 | 0.544 | 0.772 | 0.355 | 0.541 | 0.855 | 0.426 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -1.573 | -3.143 | -1.657 | -1.367 | -1.509 | -0.573 | -0.549 | -0.321 |
EBITDA Per Share | -1.573 | -3.143 | -1.657 | -1.367 | -1.509 | -0.573 | -0.549 | -0.321 |
Free Cash Flow Per Share | -1.613 | -3.143 | -1.657 | -1.354 | -1.511 | -0.575 | -0.55 | -0.32 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 9,27M | 10,63M | 14,27M | 15,59M | 19,67M | 26,66M | 25,44M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 25,44M | N/A | 38,43M | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 20,33M |
Ratio cours/bénéfice | -1,63 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 0,91 |
Ratio prix/valeur comptable | 1,22 |
Rendement de dividende | - |
Actions en circulation | 8,62M |
Volume moyen (1 semaine) | 0 |
Volume moyen (1 mois) | 0 |
Variation sur 52 semaines | -55,05% |
Plus haut sur 52 semaines | 6,7499 |
Plus bas sur 52 semaines | 2,08 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales